Cabot Corporation

NYSE:CBT

Chemicals - Specialty

Basic Materials
$74.03 +1.09%

+$0.96 today

Market cap
$3.80B
Beta
0.83
P/E (TTM)
16.3
EPS (TTM)
$5.48
Dividend yield
2.04%
52W Low $58.33High $90.08

Volume 0.53M

Average 0.43M

CBT Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Cabot CorporationNYSE: CBT

Capital Expenditures · Q3 FY2026 · quarter ended Jun 2026

Capital expenditures growth accelerates

Q3 FY2026 capital expenditures of $38M (cash outflow) rose 11.8% year over year, ahead of the -28.5% change in trailing-twelve-month capital expenditures. Sequentially, it fell 15.6% from the prior quarter. Over 3 fiscal years it compounded at +9.1% a year.

Context

  • Capital expenditures amounted to 7.4% of revenue in FY2025, up 1.3 pp from a year earlier.
  • Capital expenditures grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +11.8% holds above the trailing-twelve-month pace of -28.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$38M-15.6% QoQ
Last fiscal yearSep 2025
-$274M+13.7% YoY
LTMJun 2026
-$216M-28.5% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+11.8%——
1 year+13.7%——
3-year CAGR+9.1%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(274M) USD
Year-over-year change
-13.7%

Capital Expenditures vs competitors

How CBT compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -28.5% is the 8th highest of 11, against a peer median of -3.0%.
  • Capital expenditures amounts to 5.9% of revenue for CBT, versus a peer median of 4.5%.
CBT Competitors
Capital Expenditures for CBT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SSLSasol LimitedFY2026ZAR 20.55B ZAR-19.1%-12.6%7.7%
CECelanese CorporationLTM Jun 2026$276M USD-28.9%-14.2%2.8%
KNFKnife River CorporationLTM Jun 2026$269.62M USD-9.3%+25.0%8.2%
CBTCabot CorporationLTM Jun 2026$216M USD-28.5%+9.1%5.9%
FULH.B. Fuller CompanyLTM Aug 2026$189.33M USD+56.4%+3.1%5.3%
SXTSensient Technologies CorporationLTM Jun 2026$118.89M USD+59.8%+4.1%7.0%
AVNTAvient CorporationLTM Sep 2026$108.8M USD+3.3%+0.3%3.2%
MEOHMethanex CorporationLTM Jun 2026$57.99M USD-63.8%-44.1%1.4%
HWKNHawkins, Inc.LTM Sep 2026$56.25M USD+27.4%+6.4%4.9%
PRMPerimeter Solutions, Inc.LTM Jun 2026$30.73M USD-28.8%+50.9%4.1%
WDFCWD-40 CompanyLTM Aug 2026$7.4M USD+63.5%+2.5%1.1%
Peer median (excluding CBT) —-3.0%+2.8%4.5%

Competitors are the stored peer set for CBT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income286M243M484M424M376M
Depreciation & Amortization160M146M144M151M154M
Deferred Income Tax9M(40M)(156M)(37M)32M
Stock-Based Compensation21M23M20M25M24M
Change in Working Capital(244M)(448M)100M70M49M
Accounts Receivables7M(287M)153M(26M)76M
Inventory(174M)(259M)96M41M47M
Accounts Payables167M115M(152M)42M(67M)
Other Working Capital(244M)(17M)3M13M(7M)
Other Non-Cash Items25M176M3M59M30M
Operating Cash Flow257M100M595M692M665M
Capital Expenditures(195M)(211M)(244M)(241M)(274M)
Acquisitions (Net)(92M)70M6M00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities101M23M24M6M(24M)
Investing Cash Flow(186M)(118M)(214M)(235M)(298M)
Debt Repayment36M298M(179M)(143M)(23M)
Common Stock Issued6M6M4M20M8M
Common Stock Repurchased(3M)(53M)(98M)(172M)(168M)
Dividends Paid(80M)(84M)(88M)(93M)(96M)
Other Financing Activities(19M)(22M)(42M)(27M)(57M)
Financing Cash Flow(60M)145M(403M)(415M)(336M)
Effect of Forex Changes8M(91M)54M(57M)4M
Net Change in Cash19M36M32M(15M)35M
Free Cash Flow62M(111M)351M451M391M

Cabot Corporation

NYSE:CBT

Intrinsic Alpha fair value

Locked

Current Price

$74.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.